- Statin-associated Myasthenia Gravis
-
Kim IG, Song EC, Ha CK
- KMID: 1454835
- J Korean Neurol Assoc.
- 2010 Feb;28(1):65-66.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of statins on risk and survival of ovarian cancer
-
Khan MS, Fatima K, Rameez
- KMID: 2160812
- J Gynecol Oncol.
- 2015 Jul;26(3):240-241.
- doi: 10.3802/jgo.2015.26.3.240
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Statins in Coronary Artery Disease
-
Lim SY
- KMID: 2172169
- Chonnam Med J.
- 2013 Apr;49(1):1-6.
- doi: 10.4068/cmj.2013.49.1.1
Statins have been known to significantly reduce cardiovascular events in patients with cardiovascular disease. This review was undertaken to examine the current evidence for the effect of statins in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Ichthysiform Skin Eruptions Possibly Due to Lovastatin(Mevacor)
-
Park JH, Oh KS, Lee HJ, Whang KU
- KMID: 2303407
- Korean J Dermatol.
- 1999 Apr;37(4):535-537.
Lovastatin(Mevacor) belongs to a new generation of potent drugs for the treatment of hypercho- lesterolemia. It acts by competitive inhibition of 3-hydroxyl-3-methylglutaryl coenzyme A(HMG-CoA) reductase, diminishing in that way the... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoprevention of Gastric Cancer: Statins
-
Choi SH, Baik GH
- KMID: 2397490
- Korean J Helicobacter Up Gastrointest Res.
- 2017 Dec;17(4):175-178.
- doi: 10.7704/kjhugr.2017.17.4.175
Gastric cancer is one of the leading causes of cancer-related deaths worldwide. Because the gastric cancer-related mortality rate is expected to increase, chemo-preventive strategies for gastric cancer are required. Statins... -
- CITED
-
- Close
- SHARE
-
- Close
- Appropriate candidates for statin use in heart failure
-
Seo HS
- KMID: 2070129
- Korean J Intern Med.
- 2014 Nov;29(6):730-734.
- doi: 10.3904/kjim.2014.29.6.730
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- HMG CoA Reductase Inhibitors Inhibit HCV RNA Replication of HCV Genotype 1b but Not 2a
-
Chang KS, Jo HJ
- KMID: 2168627
- J Bacteriol Virol.
- 2011 Jun;41(2):99-108.
- doi: 10.4167/jbv.2011.41.2.99
Replication of hepatitis C virus (HCV) is regulated by statin, one of 3-hydroxy-3-methylglutaryl CoA reducatase (HMG CoA reductase) inhibitors that block mevalonate pathway and cholesterol biosyntheis, which has been used... -
- CITED
-
- Close
- SHARE
-
- Close
- A Possible Case of Statin-Induced Ichthyosis in an Elderly Woman
-
Ko KD, Kim KK, Baek JO, Suh HS, Hwang IC
- KMID: 2401724
- Korean J Fam Med.
- 2018 Jan;39(1):51-53.
- doi: 10.4082/kjfm.2018.39.1.51
Ichthyosis is a heterogeneous group of hereditary or acquired skin disorders, characterized by increased stratum corneum production. Several systemic diseases and many drugs can occasionally cause acquired ichthyosis. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- Cholesterol Lowering Therapy in Coronary Artery Disease: With Particular Reference to Statins
-
Jun JE
- KMID: 2227287
- Korean Circ J.
- 2001 Sep;31(9):849-856.
- doi: 10.4070/kcj.2001.31.9.849
Statins (HMG-CoA reductase inhibitors) are widely used lipid lowering agents. They effectively reduce LDL cholesterol (LDL-C), lower triglyceride levels and are very safe. Recent large-scale clinical trials have demonstrated that... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of HMG-CoA Reductase Inhibitors on Bone Mass in Postmenopausal Women
-
Lee SY, Kim YJ
- KMID: 2294818
- J Korean Acad Fam Med.
- 2003 May;24(5):451-455.
BACKGROUNG: It is controversial whether the use of HMG CoA reductase inhibitors (statins) is associated with an increased bone mineral density (BMD) in humans. The purpose of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Hypercholesterolemia; Management of Korean Patients in New Millennium
-
Kim CJ, Lee KJ
- KMID: 2081275
- Korean J Med.
- 2007 Jun;72(6):580-592.
Cardioprotective effect and the safety of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) has been established in many large-scaled randomized controlled trials encompassing both primary and secondary prevention. Therefore, the market of... -
- CITED
-
- Close
- SHARE
-
- Close
- Fixed-dose combination therapy for cardiovascular prevention
-
Lee SH
- KMID: 2358436
- J Korean Med Assoc.
- 2016 Nov;59(11):883-887.
- doi: 10.5124/jkma.2016.59.11.883
In patients with high cardiovascular risk, the number of drugs needed is often high, and this may decrease long-term adherence. Therefore, maintaining good adherence and reducing cardiovascular risk is currently... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on the Pharmacologic Agents for Dyslipidemia
-
Lee SH
- KMID: 2173853
- J Korean Diabetes.
- 2015 Dec;16(4):269-275.
- doi: 10.4093/jkd.2015.16.4.269
Although statins have demonstrated consistent and strong effects on cardiovascular prevention, non-statin drugs have failed to show additional clinical benefit. Consequently, statins are currently recommended as first-line therapy in dyslipidemia.... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
-
Lee SH
- KMID: 2413284
- Endocrinol Metab.
- 2017 Mar;32(1):36-40.
- doi: 10.3803/EnM.2017.32.1.36
In recent studies, the reported prevalence of heterozygous familial hypercholesterolemia (FH) has been higher than in previous reports. Although cascade genetic screening is a good option for efficient identification of... -
- CITED
-
- Close
- SHARE
-
- Close
- Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
-
Han KH
- KMID: 2422543
- Korean Circ J.
- 2018 Nov;48(11):951-963.
- doi: 10.4070/kcj.2018.0307
HMG-CoA reductase inhibitors, i.e. statins, are effective in reducing cardiovascular disease events but also in cardiac-related and overall mortality. Statins are in general well-tolerated, but currently the concerns are raised... -
- CITED
-
- Close
- SHARE
-
- Close
- In the Shadow of the "Statin Festival"
-
Kim CJ
- KMID: 2093953
- Korean Circ J.
- 2006 Feb;36(2):77-83.
- doi: 10.4070/kcj.2006.36.2.77
The efficacy of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) for reducing cardiovascular events has been established in large-scaled randomized controlled trials (RCT), and these trials have encompassed both primary and secondary... -
- CITED
-
- Close
- SHARE
-
- Close
- Myotonic Potentials in the Myopathy Induced by HMG-CoA Reductase Inhibitor
-
Kim YH, Kim KW, Ahn SH, Oh MS, Ma HI, Kim YJ, Lee BC
- KMID: 2343530
- J Korean Neurol Assoc.
- 2014 Aug;32(3):186-189.
HMG-CoA reductase inhibitor is widely used for the treatment of dyslipidemia, and for the prevention of stroke and cardiovascular disease. However, it is necessary to consider the adverse effects associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Risk of Statin Therapy
-
Choi HJ, Park JN
- KMID: 2182026
- J Korean Acad Fam Med.
- 2004 Oct;25(10):713-720.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Hypercholesterolemia in Elderly Patients; From the Viewpoint of Statins
-
Choe SC, Lee S, Kim CJ
- KMID: 1742778
- J Korean Geriatr Soc.
- 2002 Dec;6(4):253-260.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Statin-Induced Autoimmune Necrotizing Myopathy Responsive to Immunosuppressive Therapy
-
Park YE, Seo JD, Kim DS
- KMID: 1492126
- J Korean Soc Clin Neurophysiol.
- 2012 Dec;14(2):76-79.
Statin is commonly used for lowering cholesterols and can be myotoxic to cause drug-induced necrotizing myopathy. Statin-induced myopathy ranges from asymptomatic hyperCKemia to lethal rhabdomyolysis but is usually reversed by... -
- CITED
-
- Close
- SHARE
-
- Close
